- RecruitingPHASE3
Letermovir-based Dual Therapy for Treatment of Cytomegalovirus Infections
This study is testing if a drug called letermovir, when given with another drug called valganciclovir, works better for kidney transplant patients with CMV infection. We want to see if this combination helps more and reduces the risk of drug resistance.
For: Cytomegalovirus InfectionFrance - RecruitingPHASE4
Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients
This study looks at a new drug, Letermovir, combined with usual treatments for a common virus called CMV in people who have had lung transplants. We want to see if this combination clears the virus more effectively than standard treatment alone.
For: CMV · Lung Transplant RecipientCanada